Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
AbbVie Oy
OY
Active
Y-tunnus 2470310-6
Pasilan Asema-Aukio 1, 00520
Helsinki
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2012 · 14 years old
108 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
AbbVie Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
91M
68M
45M
23M
0M
2021: 51M
51M
2021
2022: 59M (+16% vs 2021)
59M
+16%
2022
2023: 60M (+2% vs 2022)
60M
+2%
2023
2024: 65M (+8% vs 2023)
65M
+8%
2024
2025: 73M (+12% vs 2024)
73M
+12%
2025
EBITDA
EUR millions
5M
4M
2M
1M
0M
2021: 2M
2M
2021
2022: 4M (+100% vs 2021)
4M
+100%
2022
2023: 4M (0% vs 2022)
4M
0%
2023
2024: 4M (0% vs 2023)
4M
0%
2024
2025: 4M (0% vs 2024)
4M
0%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
72 635
65 172
59 505
58 621
50 867
Staff expenses
−15 367
−15 275
−13 854
−12 583
−10 967
EBITDA
4 269
3 969
3 714
3 506
2 314
Depreciation & amort.
−637
−711
−739
−622
−256
EBIT
3 632
3 259
2 975
2 884
2 058
Net financials
441
747
706
139
−4
Profit before tax
4 073
4 006
3 701
3 029
2 080
Tax
925
−0
−0
644
430
Net profit
3 148
3 184
2 894
2 385
1 650
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
39 070
35 816
40 316
33 505
31 122
Equity
14 748
11 560
0
15 538
13 159
Long-term debt
0
0
0
506
721
Short-term debt
24 322
24 216
0
17 461
17 242
Total debt
24 322
24 216
0
17 967
17 963
Financial ratios
5-year trend
EBITDA margin
5,9 %
This company
15,8 %
Market median
This company
Market median
63% below market
2021
2025
Equity ratio
37,7 %
This company
38,2 %
Market median
This company
Market median
1% below market
2021
2025
Return on equity
21,3 %
This company
18,4 %
Market median
This company
Market median
16% above market
2021
2025
Net profit margin
4,3 %
This company
8,1 %
Market median
This company
Market median
47% below market
2021
2025
Asset turnover
1,86×
This company
1,12×
Market median
This company
Market median
66% above market
2021
2025
Debt / equity
1,65×
This company
0,62×
Market median
This company
Market median
166% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on AbbVie Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
